Fifth Third Bancorp Has $1.04 Million Holdings in Mettler-Toledo International, Inc. $MTD

Fifth Third Bancorp lifted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 9.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 888 shares of the medical instruments supplier’s stock after acquiring an additional 73 shares during the period. Fifth Third Bancorp’s holdings in Mettler-Toledo International were worth $1,043,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in MTD. Vanguard Group Inc. raised its stake in shares of Mettler-Toledo International by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock valued at $3,003,485,000 after purchasing an additional 30,535 shares during the period. Alliancebernstein L.P. raised its position in Mettler-Toledo International by 21.6% in the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after buying an additional 126,147 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in Mettler-Toledo International by 5.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock valued at $568,032,000 after buying an additional 25,272 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Mettler-Toledo International by 11.9% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock valued at $479,673,000 after acquiring an additional 43,082 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Mettler-Toledo International by 42.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock worth $361,030,000 after acquiring an additional 90,395 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on MTD. Citigroup boosted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Thursday, August 21st. Barclays started coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They set an “overweight” rating and a $1,325.00 price target on the stock. Bank of America raised their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Robert W. Baird upped their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Finally, Evercore ISI reduced their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $1,325.56.

Insider Buying and Selling

In other news, Director Thomas P. Salice sold 1,062 shares of the business’s stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director owned 283 shares in the company, valued at $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Gerry Keller sold 165 shares of the company’s stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares in the company, valued at $123,012.16. The trade was a 63.71% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 1,827 shares of company stock valued at $2,371,208. Company insiders own 0.77% of the company’s stock.

Mettler-Toledo International Stock Down 0.6%

NYSE:MTD opened at $1,202.72 on Monday. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01. The firm has a market capitalization of $24.78 billion, a price-to-earnings ratio of 30.46, a P/E/G ratio of 3.61 and a beta of 1.37. The stock’s 50 day moving average price is $1,269.22 and its two-hundred day moving average price is $1,184.64.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same period in the previous year, the firm earned $9.65 EPS. The firm’s revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.